Proprotein convertase subtilisin/kexin type 9 (<scp>PCSK9</scp>) and clinical outcomes in patients with end‐stage renal disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in patients with end‐stage renal disease

Published:2024-06-10 Issue:9 Volume:54 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Auer Johann¹²³^ORCID,Auer Lisa⁴

Affiliation:

1. Department of Cardiology and Intensive Care St Josef Hospital Braunau Austria

2. Department of Cardiology and Intensive Care Kepler University Hospital Linz Austria

3. Paracelsus Medical University Salzburg Austria

4. Department of Experimental Cardiology Medical University of Graz Austria

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.14262

Reference22 articles.

1. Premature cardiovascular disease in chronic renal failure

2. Chronic kidney disease management in the United Kingdom: NEOERICA project results

3. Chronic Kidney Disease

4. Uremic toxins and inflammation: metabolic pathways affected in non‐dialysis‐dependent stage 5 chronic kidney disease;Peris‐Fernández M;Biomedicine,2024

5. Uremic Toxicity: Present State of the Art

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP